In CRC, Fra-1 is strongly expressed at the invasive front of budding tumor cells, and epithelial–mesenchymal programming during cancer progression is under the control of Fra-1-mediated transcriptional activity [12]. The gene discussed is FOSL1; the disease is cancer.